Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Arista Networks, Inc.ANET · Entity 2421 | Director | August 20, 2026 | August 24, 2026 |
| CADENCE DESIGN SYSTEMS INCCDNS · Entity 2935 | Director | May 07, 2026 | May 11, 2026 |
| Dolby Laboratories, Inc.DLB · Entity 2518 | EVP & Chief Financial Officer | August 17, 2021 | August 18, 2021 |
| INTUITIVE SURGICAL INCISRG · Entity 2878 | Director | April 30, 2026 | May 01, 2026 |
| PG&E CorpPCG · Entity 3143 | Director | May 22, 2018 | May 24, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Arista Networks, Inc.
Report date August 20, 2026 · Filed August 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,770 |
Reported balance
After 2026-08-20 transaction · row 1
1 source rowRow 1 · 2026-08-20 · Exercise / conversion · Acquired 538 · Balance 31,770 F1: Each restricted stock unit represents a contingent right to receive one share of Arista Networks, Inc. Common Stock upon vesting. |
| Restricted Stock Unit-6SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,615 |
Reported balance
After 2026-08-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-08-20 · Exercise / conversion · Disposed 538 · Balance 1,615 F1: Each restricted stock unit represents a contingent right to receive one share of Arista Networks, Inc. Common Stock upon vesting. F2: The reporting person was granted RSUs on May 29, 2026. 1/4th of the shares vest on August 20, 2026 and will continue to vest at the same rate on each quarterly vest date thereafter. A quarterly vest date is the first market trading day on or after February 20, May 20, August 20, or November 20. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Arista Networks, Inc. Common Stock upon vesting.
F2: The reporting person was granted RSUs on May 29, 2026. 1/4th of the shares vest on August 20, 2026 and will continue to vest at the same rate on each quarterly vest date thereafter. A quarterly vest date is the first market trading day on or after February 20, May 20, August 20, or November 20.
CADENCE DESIGN SYSTEMS INC
Report date May 07, 2026 · Filed May 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,131 |
Reported balance
After 2026-05-07 transaction · row 1
1 source rowRow 1 · 2026-05-07 · Grant · Acquired 714 · Balance 9,131 F1: Restricted stock award fully vests on the earlier to occur of (i) the first anniversary of the Grant Date and (ii) the date of the next Annual Meeting of Stockholders that follows the Grant Date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock award fully vests on the earlier to occur of (i) the first anniversary of the Grant Date and (ii) the date of the next Annual Meeting of Stockholders that follows the Grant Date.
Dolby Laboratories, Inc.
Report date August 17, 2021 · Filed August 18, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 105,598 |
Last balance in matching sequence
After 2021-08-17 transaction · row 5
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
5 source rowsRow 1 · 2021-08-17 · Exercise / conversion · Acquired 30,000 · Balance 135,598 F1: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Row 2 · 2021-08-17 · Sale · Disposed 2,800 · Balance 132,798 F2: The shares were sold in multiple transactions at prices ranging from $101.37 to $102.35, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Row 3 · 2021-08-17 · Sale · Disposed 4,900 · Balance 127,898 F3: The shares were sold in multiple transactions at prices ranging from $100.36 to $101.29, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Row 4 · 2021-08-17 · Sale · Disposed 14,870 · Balance 113,028 F4: The shares were sold in multiple transactions at prices ranging from $99.31 to $100.29, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. Row 5 · 2021-08-17 · Sale · Disposed 7,430 · Balance 105,598 F5: This transaction was executed in multiple trades at prices ranging from $99.15 to $99.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.15 · Expires 2022-12-15 | Direct | 10,625 |
Reported balance
After 2021-08-17 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-08-17 · Exercise / conversion · Disposed 30,000 · Balance 10,625 F6: This performance-based stock option award was granted for a total of 32,500 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2018 was at 125% of target, or 40,625 shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest.
F2: The shares were sold in multiple transactions at prices ranging from $101.37 to $102.35, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3: The shares were sold in multiple transactions at prices ranging from $100.36 to $101.29, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F4: The shares were sold in multiple transactions at prices ranging from $99.31 to $100.29, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F5: This transaction was executed in multiple trades at prices ranging from $99.15 to $99.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F6: This performance-based stock option award was granted for a total of 32,500 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2018 was at 125% of target, or 40,625 shares.
INTUITIVE SURGICAL INC
Report date April 30, 2026 · Filed May 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,314 |
Reported balance
After 2026-04-30 transaction · row 1
1 source rowRow 1 · 2026-04-30 · Exercise / conversion · Acquired 531 · Balance 1,314 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-04-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-04-30 · Exercise / conversion · Disposed 531 · Balance 0 F1: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. |
| Restricted Stock Units - 4-30-2026SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 554 |
Reported balance
After 2026-04-30 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-30 · Grant · Acquired 554 · Balance 554 F1: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: 100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.
PG&E Corp
Report date May 22, 2018 · Filed May 24, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,634.24 |
Reported balance
After 2018-05-22 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-05-22 · Grant · Acquired 3,208 · Balance 26,634.24 F1: Restricted Stock Units (RSUs) granted under the PG&E Corporation 2014 Long Term Incentive Plan (LTIP). RSUs are payable in shares of PG&E Corporation common stock on a one-for-one basis. As described in the LTIP, RSUs vest upon the earliest of one year from the date of grant, the last day of the director's elected term, or a director's death, disability, or termination following a change in control. F2: This total reflects the acquisition of 27.44 RSUs on 7/17/17 and 34.42 RSUs on 10/16/17 pursuant to a dividend reinvestment feature of the LTIP. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Units (RSUs) granted under the PG&E Corporation 2014 Long Term Incentive Plan (LTIP). RSUs are payable in shares of PG&E Corporation common stock on a one-for-one basis. As described in the LTIP, RSUs vest upon the earliest of one year from the date of grant, the last day of the director's elected term, or a director's death, disability, or termination following a change in control.
F2: This total reflects the acquisition of 27.44 RSUs on 7/17/17 and 34.42 RSUs on 10/16/17 pursuant to a dividend reinvestment feature of the LTIP.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2018 Filed May 24, 2018 20:09 UTC | PG&E Corp PCG · Entity 3143 | GrantCommon Stock | 3,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-018725 · form4.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,634.24 F1 · shares: Restricted Stock Units (RSUs) granted under the PG&E Corporation 2014 Long Term Incentive Plan (LTIP). RSUs are payable in shares of PG&E Corporation common stock on a one-for-one basis. As described in the LTIP, RSUs vest upon the earliest of one year from the date of grant, the last day of the director's elected term, or a director's death, disability, or termination following a change in control. F2 · balance_after: This total reflects the acquisition of 27.44 RSUs on 7/17/17 and 34.42 RSUs on 10/16/17 pursuant to a dividend reinvestment feature of the LTIP. Read SEC document |
| May 17, 2018 Filed May 17, 2018 22:47 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,000 | $0.00 Strike: $37.96 | $0.00 |
DisclosureSEC source: 0001209191-18-031168 · doc4.xml · derivative · entry 3 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,185 Underlying: Class A Common Stock · 17,000 shares Expires 2022-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 187,185 shares of Class A Common and became fully vested on June 15, 2016. Read SEC document |
| May 17, 2018 Filed May 17, 2018 22:47 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 17,000 | $62.58 | $1,063,841.30 |
DisclosureSEC source: 0001209191-18-031168 · doc4.xml · nonDerivative · entry 2 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,370 F2 · price: This transaction was executed in multiple trades at prices ranging from $62.39 to $62.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 36,533 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| May 17, 2018 Filed May 17, 2018 22:47 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 17,000 | $37.96 | $645,320.00 |
DisclosureSEC source: 0001209191-18-031168 · doc4.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,370 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 36,533 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:43 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,000 | $0.00 Strike: $37.96 | $0.00 |
DisclosureSEC source: 0001209191-18-015157 · doc4.xml · derivative · entry 3 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,185 Underlying: Class A Common Stock · 17,000 shares Expires 2022-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 187,185 shares of Class A Common and became fully vested on June 15, 2016. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:43 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 17,000 | $63.15 | $1,073,497.30 |
DisclosureSEC source: 0001209191-18-015157 · doc4.xml · nonDerivative · entry 2 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,370 F2 · price: This transaction was executed in multiple trades at prices ranging from $63 to $63.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 36,533 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:43 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 17,000 | $37.96 | $645,320.00 |
DisclosureSEC source: 0001209191-18-015157 · doc4.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,370 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 36,533 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 01:53 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 2,544 | $62.32 | $158,542.08 |
DisclosureSEC source: 0001209191-17-066569 · doc4.xml · nonDerivative · entry 3 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,370 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F5 · balance_after: Shares held following the reported transactions include 36,533 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2017 Filed Dec 20, 2017 01:53 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 56,000 | $0.00 Strike: $62.32 | $0.00 |
DisclosureSEC source: 0001209191-17-066569 · doc4.xml · derivative · entry 5 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,000 Underlying: Class A Common Stock · 56,000 shares Expires 2027-12-15 F7 · derivative.exercise_date: This option was granted for a total of 56,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2017, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 15, 2017 Filed Dec 20, 2017 01:53 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Stock Option (Right to Buy) · Derivative | 28,000 | $0.00 Strike: $62.32 | $0.00 |
DisclosureSEC source: 0001209191-17-066569 · doc4.xml · derivative · entry 4 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Class A Common Stock · 28,000 shares Expires 2024-12-15 F6 · derivative.exercise_date: The vesting of this performance-based stock option ("PSO") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2017 and ending December 15, 2020. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 125% of the target award amount based on total shareholder return at the end of the three-year performance period. The actual PSO award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 15, 2017 Filed Dec 20, 2017 01:53 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-066569 · doc4.xml · nonDerivative · entry 2 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,914 F3 · acquired: Award represents a total of 14,000 restricted stock units granted under the terms of the Issuer's 2005 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2017. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F4 · balance_after: Shares held following the reported transactions include 41,408 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2017 Filed Dec 20, 2017 01:53 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 5,985 | $60.99 | $365,025.15 |
DisclosureSEC source: 0001209191-17-066569 · doc4.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,914 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 27,408 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 10, 2017 Filed Nov 13, 2017 22:10 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,000 | $0.00 Strike: $37.96 | $0.00 |
DisclosureSEC source: 0001209191-17-060358 · doc4.xml · derivative · entry 3 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,185 Underlying: Class A Common Stock · 17,000 shares Expires 2022-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 187,185 shares of Class A Common and became fully vested on June 15, 2016. Read SEC document |
| November 10, 2017 Filed Nov 13, 2017 22:10 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 17,000 | $59.55 | $1,012,319.40 |
DisclosureSEC source: 0001209191-17-060358 · doc4.xml · nonDerivative · entry 2 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,899 F2 · price: This transaction was executed in multiple trades at prices ranging from $59.51 to $59.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 38,879 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 10, 2017 Filed Nov 13, 2017 22:10 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 17,000 | $37.96 | $645,320.00 |
DisclosureSEC source: 0001209191-17-060358 · doc4.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,899 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 38,879 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| May 30, 2017 Filed May 31, 2017 22:42 UTC | PG&E Corp PCG · Entity 3143 | GrantCommon Stock | 2,062 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-019892 · form4.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,364.38 F1 · shares: Restricted Stock Units (RSUs) granted under the PG&E Corporation 2014 Long Term Incentive Plan (LTIP). RSUs are payable in shares of PG&E Corporation common stock on a one-for-one basis. As described in the LTIP, RSUs vest upon the earliest of one year from the date of grant, the last day of the director's elected term, or a director's death, disability, or termination following a change in control. F2 · balance_after: This total reflects the acquisition of 28.10 RSUs on 7/15/16, 30.29 RSUs on 10/17/16, 29.85 RSUs on 1/17/17, and 27.55 RSUs on 4/17/17 pursuant to a dividend reinvestment feature of the LTIP. Read SEC document |
| May 17, 2017 Filed May 17, 2017 23:44 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 14,300 | $0.00 Strike: $30.49 | $0.00 |
DisclosureSEC source: 0001209191-17-033440 · doc4.xml · derivative · entry 3 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,400 Underlying: Class A Common Stock · 14,300 shares Expires 2022-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 98,700 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 21, 2012, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| May 17, 2017 Filed May 17, 2017 23:44 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 14,300 | $50.34 | $719,856.28 |
DisclosureSEC source: 0001209191-17-033440 · doc4.xml · nonDerivative · entry 2 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,899 F2 · price: This transaction was executed in multiple trades at prices ranging from $50.25 to $50.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 38,879 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| May 17, 2017 Filed May 17, 2017 23:44 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 14,300 | $30.49 | $436,007.00 |
DisclosureSEC source: 0001209191-17-033440 · doc4.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 38,879 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 21, 2016 Filed Dec 23, 2016 00:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 3,001 | $46.30 | $138,946.30 |
DisclosureSEC source: 0001209191-16-156598 · doc4.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,899 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incident to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 38,879 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2016 Filed Dec 20, 2016 00:13 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 2,544 | $45.86 | $116,667.84 |
DisclosureSEC source: 0001209191-16-156011 · doc4.xml · nonDerivative · entry 3 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,900 F3 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incident to the vesting of restricted stock units. F5 · balance_after: Shares held following the reported transactions include 44,629 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2016 Filed Dec 20, 2016 00:13 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 56,000 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001209191-16-156011 · doc4.xml · derivative · entry 5 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,000 Underlying: Class A Common Stock · 56,000 shares Expires 2026-12-15 F7 · derivative.exercise_date: This option was granted for a total of 56,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2016, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 15, 2016 Filed Dec 20, 2016 00:13 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Stock Option (Right to Buy) · Derivative | 28,000 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001209191-16-156011 · doc4.xml · derivative · entry 4 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Class A Common Stock · 28,000 shares Expires 2023-12-15 F6 · derivative.exercise_date: The vesting of this performance-based stock option ("PSO") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2016 and ending December 15, 2019. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 125% of the target award amount based on total shareholder return at the end of the three-year performance period. The actual PSO award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 15, 2016 Filed Dec 20, 2016 00:13 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 4,160 | $45.50 | $189,280.00 |
DisclosureSEC source: 0001209191-16-156011 · doc4.xml · nonDerivative · entry 2 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,444 F3 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incident to the vesting of restricted stock units. F4 · balance_after: Shares held following the reported transactions include 49,503 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2016 Filed Dec 20, 2016 00:13 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-156011 · doc4.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,604 F1 · acquired: Award represents a total of 14,000 restricted stock units granted under the terms of the Issuer's 2005 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2016. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2 · balance_after: Shares held following the reported transactions include 57,473 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 21, 2016 Filed Nov 22, 2016 21:41 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $30.49 | $0.00 |
DisclosureSEC source: 0001209191-16-151726 · doc4.xml · derivative · entry 3 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,700 Underlying: Class A Common Stock · 15,000 shares Expires 2022-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted for a total of 98,700 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 21, 2012, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter. Read SEC document |
| November 21, 2016 Filed Nov 22, 2016 21:41 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 15,000 | $46.85 | $702,750.00 |
DisclosureSEC source: 0001209191-16-151726 · doc4.xml · nonDerivative · entry 2 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,604 F1 · balance_after: Shares held following the reported transactions include 43,473 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 21, 2016 Filed Nov 22, 2016 21:41 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 15,000 | $30.49 | $457,350.00 |
DisclosureSEC source: 0001209191-16-151726 · doc4.xml · nonDerivative · entry 1 CHEW LEWIS · CIK 0001224994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 43,473 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.